Generate Biomedicines has been named to Fierce Biotech’s 2022 “Fierce 15” list. This annual list celebrates the spirit of being “fierce” – championing innovation and creativity, even in the face of intense competition.
As an internationally recognized daily report, Fierce Biotech provides its network of 450,000 biotech and pharma industry subscribers with an analysis of the day’s top stories. For its annual Fierce 15 list, Fierce Biotech evaluates hundreds of early-stage companies from around the world based on various factors, such as the strength of their technology, partnerships, venture backers, and competitive market position.
Generate and the other winners will be announced and recognized during the Fierce Biotech Summit on September 19, 2022, in Boston, Massachusetts.